The landscape of tolerated genetic variation in humans and primates
Illumina (United States) · Broad Institute · +74 more institutions
Abstract
Personalized genome sequencing has revealed millions of genetic differences between individuals, but our understanding of their clinical relevance remains largely incomplete. To systematically decipher the effects of human genetic variants, we obtained whole-genome sequencing data for 809 individuals from 233 primate species and identified 4.3 million common protein-altering variants with orthologs in humans. We show that these variants can be inferred to have nondeleterious effects in humans based on their presence at high allele frequencies in other primate populations. We use this resource to classify 6% of all possible human protein-altering variants as likely benign and impute the pathogenicity of the…
Citation impact
- FWCI
- 50.68
- Percentile
- 100%
- References
- 161
Authors
97Topics & keywords
- Biology
- Genetic variation
- Genome
- Genetics
- Primate
- Human genome
- Allele
- Human genetic variation
Funding
- NSNational Science FoundationAwards: 1219368, 1540255, 1848954, BNS83-03506, 100010434, 1952072, 1026991, NSF-BCS-0621020, 0621020, REU 0837921, 1029451, 1232349, 0837921, 1503753
- GAGordon and Betty Moore Foundation
- PCPrimate Conservation
- LFLeakey Foundation
- NGNational Geographic Society
- MMMargot Marsh Biodiversity Foundation
- MOMinistry of Science and Technology
- RFRufford Foundation
- IIIndian Institute of Science
- BIBroad Institute
- URUK Research and Innovation
- CDCentres de Recerca de CatalunyaAward: 501100011033
- SRSight Research UKAward: NE/T000341/1
- ECEuropean CommissionAwards: 100010434, 864203, 847648, 13039/501100011033, 801505, 501100011033, 2014-2020, ID 100010434
- NRNational Research Foundation
- NRNational Research Foundation SingaporeAward: MOH-000588
- DODepartment of Biotechnology, Ministry of Science and Technology, India
- COCouncil of Scientific and Industrial Research, India
- DFDeutsche ForschungsgemeinschaftAward: KN1097/3-1
- CRCanada Research Chairs
- VSVienna Science and Technology FundAwards: VRG20001, 10.47379/VRG20001
- CDCoordenação de Aperfeiçoamento de Pessoal de Nível SuperiorAwards: 2014-5, 3261/2013
- GDGeneralitat de CatalunyaAwards: 501100011033, BFU2017-86471-P, CEX2018-000792-M, 864203
- CNConselho Nacional de Desenvolvimento Científico e TecnológicoAwards: 302140/2020-4, 563348/2010, 563348/2010-0, 2014-5, 47379
- VVetenskapsrådetAwards: BFU2017-86471-P, 864203, CEX2018-000792-M, 2020-03398
- MDMinisterio de Ciencia e InnovaciónAwards: MCIN/AEI/10, 847648, 100010434, CEX2018-000792-M, 501100011033, AEI/10, ID 100010434, 13039/501100011033
- FDFundação de Amparo à Pesquisa do Estado do AmazonasAward: 563348/2010-0
- IDInstituto de Desenvolvimento Sustentável Mamirauá
- FBFundación Bancaria Caixa d'Estalvis i Pensions de BarcelonaAwards: ID 100010434, 100010434
- NINational Institutes of HealthAwards: 100010434, T32 GM007748, GM007748, P40OD024628, 1R01HG010898-01A1
- MRMedical Research Council
- NENatural Environment Research CouncilAwards: NE/T000341/1, NE/T000341/1
- NMNational Medical Research CouncilAward: MOH-000588
- IDInstituto de Salud Carlos III
- EREuropean Regional Development FundAwards: MCIN/AEI/10, BFU2017-86471-P, BIO2015-71792-P, 13039/501100011033, 2014-2020, 100010434, 501100011033, 864203, CEX2018-000792-M
- AEAgencia Estatal de InvestigaciónAwards: CEX2018-000792-M, 501100011033, 13039, 864203, AEI/10, 13039/501100011033, BFU2017-86471-P
- NINational Institute on AgingAwards: R24 HD-044964, P30 AG012836-19, P30 AG012836, 100010434